One of the silver linings of the pandemic is that Americans are fostering more animals than ever during this time, “bringing furry friends across the country into loving homes,” Hirschhorn said. Now, he applies that experience to a booming pet care industry that is influenced by an increased consumer focus on wellness, millennial lifestyle trends and advances in health technology. We’re doing this at a tenth of the cost of existing therapies today.” Also in Gallant’s favor: the pet sector benefits from less regulation than there is for stem cell therapy and research and treatment for humans.Įxperienced in the pet startup space, Hirschhorn founded digital pet-sitting community DogVacay over a decade ago. “It’s an unnecessary surgery on a dog that’s already sick. “Today’s method of animal stem cell therapy costs $3,000 to $4,000,” Hirschhorn told CO-, explaining his imperative for creating the company. Working with a team of scientists, Hirschhorn’s goal with Gallant is to make regenerative medicine for pets as accessible and non-invasive as possible.
So thought entrepreneur Aaron Hirschhorn, founder of Gallant, whose experience healing his own chronic back pain with stem cell therapy inspired him to consider similar treatment for his arthritic dog, Rocky. And with consumers increasingly focused on wellness and preventative care, why not invest in the future health of family pets as well? Pets are considered a bona fide member of the family in many households. Gallant founder Aaron Hirschhorn has based the premise of his business on the increased consumer focus on wellness, millennial lifestyle trends and advances in health technology.
0 kommentar(er)
